Literature DB >> 10868329

ECT in the presence of brain tumor and increased intracranial pressure: evaluation and reduction of risk.

A A Patkar1, K P Hill, S P Weinstein, S L Schwartz.   

Abstract

The presence of brain tumor and increased intracranial pressure has long been considered an absolute contraindication to electroconvulsive therapy. Recently, however, the American Psychiatric Association Task Force Report questioned the absolute nature of this contraindication and recommended a detailed evaluation of the risk-benefit ratio and measures to decrease the risks involved in treatment of affected persons. After a careful review, electroconvulsive therapy was administered to a 61-year-old patient who had severe medication-resistant major depression and a left temporal anaplastic astrocytoma with brain edema. Special attention was given to reduce intracranial pressure and minimize neurologic side effects. A course of eight nondominant unilateral electroconvulsive therapy treatments improved the depression significantly, without serious complications at the 4-month follow-up examination. With appropriate modifications, electroconvulsive therapy may be considered a treatment option even in the presence of clinical evidence of increased intracranial pressure. Further studies are needed to assess and minimize risks of electroconvulsive therapy in association with brain tumor.

Entities:  

Mesh:

Year:  2000        PMID: 10868329     DOI: 10.1097/00124509-200006000-00011

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  3 in total

Review 1.  Electroconvulsive therapy in the medically ill.

Authors:  Eric J Christopher
Journal:  Curr Psychiatry Rep       Date:  2003-07       Impact factor: 5.285

Review 2.  The relationships between depression and brain tumors.

Authors:  N Scott Litofsky; Andrew G Resnick
Journal:  J Neurooncol       Date:  2009-03-05       Impact factor: 4.130

3.  Electroconvulsive therapy for medication-refractory depression in a patient with ruptured intracranial dermoid cyst, meningioma, and neurofibromatosis.

Authors:  Priyanka Thukral-Mahajan; Nilesh Shah; Gurvinder Kalra; Chittaranjan Andrade
Journal:  Indian J Psychiatry       Date:  2017 Oct-Dec       Impact factor: 1.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.